FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Guillaume Cartron

Research Profile

Chemicals & Drugs

Disorders

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Gandhi Damaj; Momar Diouf; Rémy Gressin; Emmanuel Gyan; Roch Houot; Arnaud Jaccard; Bertrand Joly; Steven Le Gouill; Jean-Pierre Marolleau; Antoine Martin; Sophie Park; Alain Saad; Laurence Sanhes; Jean-Marc Schiano-de Collela; Aline Schmidt-Tanguy; Olivier Tournilhac; Jean-Pierre Vilque; Laurent Voillat; Anne Banos; Marie-Christine Béné; Krimo Bouabdallah; Michael Bubenheim; Guillaume Cartron; Bachra Choufi; Pascale Cony-Makhoul; Thierry Lamy
Results from a prospective, open-label, phase II trial of bendamustine in refractory or relapsed T-cell lymphomas: the BENTLY trial.
Hervé Ghesquières; Fabrice Jardin; Fritz Offner; Aurore Perrot; John Francis Seymour; Anne Sonet; Pierre Soubeyran; Aurélie Verney; Réda Bouabdallah; Pauline Brice; Guillaume Cartron; Olivier Casasnovas; John Vincent Catalano; Peggy Dartigues; Marie-Hélène Delfau-Larue; Alain Delmer; Jehan Dupuis; Gilles SALLES
Clinical outcome of patients with follicular lymphoma receiving chemoimmunotherapy in the PRIMA study is not affected by FCGR3A and FCGR2A polymorphisms.
Myron S Czuczman; Vincent Delwail; Christine G DiRienzo; Luis Fayad; Eve Gallop-Evans; Nancy Goldstein; Ira Gupta; Anton Hagenbeek; Andrzej Hellmann; Eric Jacobsen; Roxanne C Jewell; Kazimierz Kuliczkowski; Thomas S Lin; Brian K Link; Steen Lisby; Lauren Pinter-Brown; John Radford; Charlotte A Russell; Martin Schultz; Guillaume Cartron
Ofatumumab monotherapy in rituximab-refractory follicular lymphoma: results from a multicenter study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Guillaume Cartron (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Gandhi Damaj; Momar Diouf; Rémy Gressin; Emmanuel Gyan; Roch Houot; Arnaud Jaccard; Bertrand Joly; Steven Le Gouill; Jean-Pierre Marolleau; Antoine Martin; Sophie Park; Alain Saad; Laurence Sanhes; Jean-Marc Schiano-de Collela; Aline Schmidt-Tanguy; Olivier Tournilhac; Jean-Pierre Vilque; Laurent Voillat; Anne Banos; Marie-Christine Béné; Krimo Bouabdallah; Michael Bubenheim; Guillaume Cartron; Bachra Choufi; Pascale Cony-Makhoul; Thierry Lamy
Results from a prospective, open-label, phase II trial of bendamustine in refractory or relapsed T-cell lymphomas: the BENTLY trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(1):104-10.
2012: Hervé Ghesquières; Fabrice Jardin; Fritz Offner; Aurore Perrot; John Francis Seymour; Anne Sonet; Pierre Soubeyran; Aurélie Verney; Réda Bouabdallah; Pauline Brice; Guillaume Cartron; Olivier Casasnovas; John Vincent Catalano; Peggy Dartigues; Marie-Hélène Delfau-Larue; Alain Delmer; Jehan Dupuis; Gilles SALLES
Clinical outcome of patients with follicular lymphoma receiving chemoimmunotherapy in the PRIMA study is not affected by FCGR3A and FCGR2A polymorphisms.
Blood 2012;120(13):2650-7.
2012: Myron S Czuczman; Vincent Delwail; Christine G DiRienzo; Luis Fayad; Eve Gallop-Evans; Nancy Goldstein; Ira Gupta; Anton Hagenbeek; Andrzej Hellmann; Eric Jacobsen; Roxanne C Jewell; Kazimierz Kuliczkowski; Thomas S Lin; Brian K Link; Steen Lisby; Lauren Pinter-Brown; John Radford; Charlotte A Russell; Martin Schultz; Guillaume Cartron
Ofatumumab monotherapy in rituximab-refractory follicular lymphoma: results from a multicenter study.
Blood 2012;119(16):3698-704.
2012: David Ternant; Michel Tod; Guillaume Cartron; Pascal Girard; Emilie Hénin; Gilles Paintaud
Model-based design of rituximab dosage optimization in follicular non-Hodgkin's lymphoma.
British journal of clinical pharmacology 2012;73(4):597-605.
2011: Steven Le Gouill; Lucie Planche; Gilles SALLES; Hervé Tilly; Achiel Van Hoof; Michel Blanc; Pauline Brice; Guillaume Cartron; Olivier Casasnovas; SOPHIE DE GUIBERT; Eric DECONINCK; Vincent Delwail; Jehan Dupuis; Olivier Fitoussi; Charles Foussard; Christophe Fruchart; Jean Gabarre; Lauris Gastaud; Rémy Gressin; Emmanuel Gyan
Impact of the use of autologous stem cell transplantation at first relapse both in naive and previously rituximab exposed follicular lymphoma patients treated in the GELA/GOELAMS FL2000 study.
Haematologica 2011;96(8):1128-35.
2009: David Ternant; Emilie Hénin; Guillaume Cartron; Michel Tod; Gilles Paintaud; Pascal Girard
Development of a drug-disease simulation model for rituximab in follicular non-Hodgkin's lymphoma.
British journal of clinical pharmacology 2009;68(4):561-73.
2009: David Daydé; David Ternant; Marc Ohresser; Stéphanie Lerondel; Sabrina Pesnel; Hervé Watier; Alain Le Pape; Pierre Bardos; Gilles Paintaud; Guillaume Cartron
Tumor burden influences exposure and response to rituximab: pharmacokinetic-pharmacodynamic modeling using a syngeneic bioluminescent murine model expressing human CD20.
Blood 2009;113(16):3765-72.
2008: Guillaume Cartron; Marc Ohresser; Gilles SALLES; P Solal-Céligny; Philippe Colombat; H Watier
Neutrophil role in in vivo anti-lymphoma activity of rituximab: FCGR3B-NA1/NA2 polymorphism does not influence response and survival after rituximab treatment.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(8):1485-7.
2007: Hélène Blasco; Gilles Lalmanach; Emmanuel Godat; Marie-Christine Maurel; S Canepa; Maya Belghazi; Gilles Paintaud; Danielle Degenne; E Chatelut; Guillaume Cartron; Chantal Le Guellec
Evaluation of a peptide ELISA for the detection of rituximab in serum.
Journal of immunological methods 2007;325(1-2):127-39.
2007: Guillaume Cartron; Hélène Blasco; Gilles Paintaud; Hervé Watier; Chantal Le Guellec
Pharmacokinetics of rituximab and its clinical use: thought for the best use?
Critical reviews in oncology/hematology 2007;62(1):43-52.
2007: Séverine Loisel; Marc Ohresser; Marc Pallardy; David Daydé; Christian Berthou; Guillaume Cartron; Hervé Watier
Relevance, advantages and limitations of animal models used in the development of monoclonal antibodies for cancer treatment.
Critical reviews in oncology/hematology 2007;62(1):34-42.
2006: Florence Dommange; Guillaume Cartron; Claire Espanel; Nathalie Gallay; Jorge Domenech; Lotfi Benboubker; Marc Ohresser; Philippe Colombat; Christian Binet; Hervé Watier; Olivier Herault
CXCL12 polymorphism and malignant cell dissemination/tissue infiltration in acute myeloid leukemia.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2006;20(11):1913-5.
2005: David Ternant; Marc Ohresser; Cécile Thomas; Guillaume Cartron; Hervé Watier; Gilles Paintaud
Dose-response relationship and pharmacogenetics of anti-RhD monoclonal antibodies.
Blood 2005;106(4):1503-4; author reply 1504-5.
2005: Marc Bernard; Guillaume Cartron; Petronella Rachieru; Annick LeMevel; Bernard Branger; Catherine Le Maignan; Christian Berthou; Christiane Ghandour; Vincent Delwail; Noël Milpied; Philippe Cassasus; Philippe Solal Celigny; Denis Guyotat; Thierry Lamy; Bernard Desablens
Long-term outcome of localized high-grade non-Hodgkin's lymphoma treated with high dose CHOP regimen and involved field radiotherapy: results of a GOELAMS study.
Haematologica 2005;90(6):802-9.
2005: Elena Cittera; Chiara Onofri; Maria D'Apolito; Guillaume Cartron; Giovanni Cazzaniga; Leopoldo Zelante; Paolo Paolucci; Andrea Biondi; Martino Introna; Josée Golay
Rituximab induces different but overlapping sets of genes in human B-lymphoma cell lines.
Cancer immunology, immunotherapy : CII 2005;54(3):273-86.
2004: Guillaume Cartron; Hervé Watier; Josée Golay; Philippe Solal-Celigny
From the bench to the bedside: ways to improve rituximab efficacy.
Blood 2004;104(9):2635-42.
2004: Sébastien Dall'Ozzo; Sophie Tartas; Gilles Paintaud; Guillaume Cartron; Philippe Colombat; Pierre Bardos; Hervé Watier; Gilles Thibault
Rituximab-dependent cytotoxicity by natural killer cells: influence of FCGR3A polymorphism on the concentration-effect relationship.
Cancer research 2004;64(13):4664-9.
2003: Guillaume Cartron; Christian Binet; Olivier Hérault; C Cailliot; Marie-Christine Bernard; M H Estienne; N Clément; Philippe Colombat; Jorge Domenech
Proliferation of human progenitor cells in a long-term culture system is more efficiently sustained by the addition of Flt-3 ligand or megakaryocyte growth and development factor than by Kit ligand.
International journal of hematology 2003;77(2):133-41.
2003: Lotfi Benboubker; Guillaume Cartron; Françoise Roingeard; Martine Delain; Michel Degenne; Claude Linassier; Olivier Hérault; Danielle Truglio; Myrtille Bout; André Petit; Jean Louis Brémond; Isabelle Desbois; Philippe Colombat; Christian Binet; Jorge Domenech
Long-term marrow reconstitutive ability of autologous grafts in lymphoma patients using peripheral blood mobilized with granulocyte colony-stimulating factor or granulocyte-macrophage colony-stimulating factor compared to bone marrow.
Experimental hematology 2003;31(1):89-97.
2002: Guillaume Cartron; Olivier Herault; Lotfi Benboubker; Nathalie Clement; Marie-Christine Bernard; Françoise Roingeard; Isabelle Desbois; Philippe Colombat; Christian Binet; Jorge Domenech
Quantitative and qualitative analysis of the human primitive progenitor cell compartment after autologous stem cell transplantation.
Journal of hematotherapy & stem cell research 2002;11(2):359-68.
2002: Jorge Domenech; Guillaume Cartron; Nathalie Clement; M-H Estienne; Olivier Herault; Danielle Truglio; Lotfi Benboubker; Françoise Roingeard; Isabelle Desbois; Philippe Colombat; Christian Binet
Persistent decrease in proliferative potential of marrow CD34(+)cells exposed to early-acting growth factors after autologous bone marrow transplantation.
Bone marrow transplantation 2002;29(7):557-62.
2002: Guillaume Cartron; Laurent Dacheux; Gilles SALLES; Philippe Solal-Celigny; Pierre Bardos; Philippe Colombat; Hervé Watier
Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene.
Blood 2002;99(3):754-8.
2002: Lotfi Benboubker; Christian Binet; Guillaume Cartron; Marie-Christine Bernard; Nathalie Clement; Martine Delain; Michel Degenne; Isabelle Desbois; Philippe Colombat; Jorge Domenech
Frequency and differentiation capacity of circulating LTC-IC mobilized by G-CSF or GM-CSF following chemotherapy: a comparison with steady-state bone marrow and peripheral blood.
Experimental hematology 2002;30(1):74-81.
2001: Guillaume Cartron; Laurent Voillat; Bernard Desablens; Christine Le Maignan; Noël Milpied; Charles Foussard; Jacqueline Dugay; Abdallah Maakaroun; Anne De Muret; Philippe Colombat
Continuous infusion of vincristine-doxorubicin with bolus of dexamethasone(VAD) alternated with CHEP in the treatment of patients over 60 years old with aggressive non-Hodgkin's lymphoma.
Leukemia & lymphoma 2001;40(5-6):529-40.
2000: Lotfi Benboubker; C Valat; Claude Linassier; Guillaume Cartron; Martine Delain; Myrtille Bout; F Fetissof; T Lefranq; JP Lamagnere; Philippe Colombat
A new serologic index for low-grade non-Hodgkin's lymphoma based on initial CA125 and LDH serum levels.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(11):1485-91.
2000: Claude Linassier; C Barin; G Calais; S Letortorec; Jean Louis Brémond; Martine Delain; A Petit; Marie Therese Georget; Guillaume Cartron; N Raban; Lotfi Benboubker; R Leloup; Christian Binet; J P Lamagnère; Philippe Colombat
Early secondary acute myelogenous leukemia in breast cancer patients after treatment with mitoxantrone, cyclophosphamide, fluorouracil and radiation therapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(10):1289-94.
2000: Guillaume Cartron; annie-pierre jonville-bera; Elisabeth Autret-Leca; P Colombat
Glimepiride-induced thrombocytopenic purpura.
The Annals of pharmacotherapy 2000;34(1):120.
1999: Guillaume Cartron; P Roingeard; Lotfi Benboubker; L Vaillant; S Tartas; Martine Delain; T Lefranc; Jean Louis Brémond; Myrtille Bout; Claude Linassier; Philippe Colombat
Sezary syndrome in a patient with multiple myeloma: demonstration of a clonally distinct second malignancy.
European journal of haematology 1999;63(5):354-7.
1999: Martine Delain; Guillaume Cartron; Myrtille Bout; Lotfi Benboubker; Claude Linassier; JP Lamagnere; Philippe Colombat
Intensive therapy with autologous stem cell transplantation as first-line therapy in poor-risk Hodgkin's disease and analysis of predictive factors of outcome.
Leukemia & lymphoma 1999;34(3-4):305-13.
1998: Guillaume Cartron; Claude Linassier; JL Bremond; Bernard Desablens; Marie Therese Georget; Béatrice Fimbel; F Luthier; J L Dutel; JP Lamagnere; Philippe Colombat
CD5 negative B-cell chronic lymphocytic leukemia: clinical and biological features of 42 cases.
Leukemia & lymphoma 1998;31(1-2):209-16.